Clinical Trial

Heart Rehabilitation for All

Study acronym: HeRTA
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Today, 50 % of cardiac patients do not participate in cardiac rehabilitation due difficulties in navigating and accessing rehabilitation activities. HeRTA is a partnership project involving Center for Clinical Research and Prevention (CCRP), Hvidovre Hospital, Rehabilitation Center Albertslund and Copenhagen (municipalities), the Danish Heart Association, and local sports associations. A patient advisory board participate throughout the project to ensure a continued focus on patient interests. The overall aim of HeRTA is to develop and test the feasibility of a new, sustainable model for rehabilitation supporting patients to take part in rehabilitation and promoting life-long activity for all patients with heart disease. To ensure equal access to rehabilitation some activities are open to all patients, while others are tailored specifically to patients with vulnerability. The project unfolds in three phases: Development (1. January 1. 2020 - 14. November 2021): Partners and patients co-create content and procedures; Feasibility (15. November 2021 - 31. July 2023): The feasibility of the model is tested, and promising components are identified; Long-term follow-up and implementation (1. August 2023 - 31. December 2025): Long term effects are investigated and promising components are tested in new settings. During the feasibility phase the investigators will examine whether the intervention activities are feasible, acceptable, and may have positive effects for patients with heart disease. The investigators use qualitative data on implementation and acceptability of intervention among partners and patients. An randomisered controlled trial (RCT) component will assess effects on patient participation rates, health, physical activity level, and life quality. Data is collected from practitioners and patients through focus groups, observations, field notes, questionnaires, and interviews. Results will point to: * innovative ways to organize integrated rehabilitation pathways. * approaches to ensuring rehabilitation targeted at patient needs.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-10-21; most recent amendment 2024-08-23.
Status change: Recruiting → Active, Not Recruiting 2024-08-23
Status change: Not Yet Recruiting → Recruiting 2022-05-11
Trial Details
NCT Number NCT05104658
Lead Sponsor Center for Clinical Research and Prevention
Collaborators: Danish Heart Foundation, Hvidovre University Hospital, Albertslund Municipality
Conditions Ischemic Heart Disease, Cardiac Valve Surgery, Persistent Atrial Fibrillation, Heart Failure
Enrollment 218 participants
Start Date 2022-04-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-26